Bacteria, viruses, and parasites are harmful microorganisms that cause infectious diseases.
Early detection of diseases is critical to prevent disease transmission and provide epidemic …

Continued elucidation of the mechanisms of hepatic fibrosis has yielded a comprehensive
and nuanced portrait of fibrosis progression and regression. The paradigm of hepatic …

Background The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and
the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection. Data …

Fibrosis is a common pathological process for the majority of liver diseases which in a
significant minority of patients leads to end-stage cirrhosis and/or hepatocellular carcinoma …

Systemic immune activation has emerged as an essential component of the
immunopathogenesis of HIV. It not only leads to faster disease progression, but also to …

Aims The Korean Association for the Study of the Liver (KASL) Practice Guidelines for
Management of Hepatitis C were first established in 2004, and revised in 2013, when direct …

HCV and HIV co-infection is associated with accelerated hepatic fibrosis progression and
higher rates of liver decompensation and death compared to HCV monoinfection, and liver …

Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)
develop more rapid fibrosis than those infected with HCV only. In HIV/HCV‐coinfected …

Objective: Liver disease secondary to hepatitis C virus (HCV) infection in the context of HIV
infection is one of the leading non-AIDS causes of death. Sexual transmission of HCV …

Lipodystrophy is a group of clinically heterogeneous, inherited or acquired, disorders
characterized by complete or partial absence of subcutaneous adipose tissue that may …